GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Philogen Spa (STU:78Q) » Definitions » Net Income Including Noncontrolling Interests

Philogen Spa (STU:78Q) Net Income Including Noncontrolling Interests : €-6.16 Mil (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Philogen Spa Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Philogen Spa's Net Income Including Noncontrolling Interests for the six months ended in Dec. 2023 was €-13.83 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Dec. 2023 was €-6.16 Mil.

Philogen Spa Net Income Including Noncontrolling Interests Historical Data

The historical data trend for Philogen Spa's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Philogen Spa Net Income Including Noncontrolling Interests Chart

Philogen Spa Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Net Income Including Noncontrolling Interests
-13.29 -15.73 -5.38 -6.16

Philogen Spa Semi-Annual Data
Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Net Income Including Noncontrolling Interests Get a 7-Day Free Trial -7.07 1.98 -7.36 7.67 -13.83

Philogen Spa Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-6.16 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Philogen Spa Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of Philogen Spa's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.

Philogen Spa (STU:78Q) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Philogen Spa (STU:78Q) » Definitions » Net Income Including Noncontrolling Interests
Comparable Companies
MIL:UBM MIL:ABS OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX BGNE SZSE:300122 ALNY OCSE:GMAB XKRX:068270 BMRN XBRU:UCB RPRX
Traded in Other Exchanges
PHIL:Italy
Address
Piazza La Lizza No. 7, Siena, ITA, 53100
Website
https://www.philogen.com
Philogen Spa is a biotechnology company. The company develops biotech products for the imaging and therapy of life-threatening diseases. Its pipeline products include Nidlegy; Fibromun; Darleukin; Dodekin; Dekavil and others. Geographically, it derives a majority of revenue from the USA.

Philogen Spa (STU:78Q) Headlines

No Headlines